Is botulinum toxin type A intraprostatic injections really effective in patients with urinary retention?

Acta Poloniae Pharmaceutica - Drug Research

Volumn 68, Issue 5, 2011, Pages 765-768

  Jasiński, Miłosz ^a,b   Drewa, Tomasz ^a,b   Tyloch, Janusz ^b   Wolski, Zbigniew ^b  

^a Regional Oncology Centre Bydgoszcz   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Botulinum toxin; BPH; Prostate; Urinary retention

Indexed keywords

BOTULINUM TOXIN A;

AGED; ANIMAL TISSUE; ARTICLE; CATHETER; CELL CULTURE; CLINICAL ARTICLE; DRUG EFFECT; FIBROBLAST; HUMAN; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROSTATE ADENOMA; PROSTATE HYPERTROPHY; URINE RETENTION; ANIMAL; CELL COUNT; CELL PROLIFERATION; CELL STRAIN 3T3; DOSE RESPONSE; INJECTION; PROSTATE; STROMA CELL;

3T3 CELLS; AGED; AGED, 80 AND OVER; ANIMALS; BOTULINUM TOXINS, TYPE A; CELL COUNT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; INJECTIONS; MALE; MICE; PROSTATE; STROMAL CELLS; URINARY RETENTION;

EID: 80054042225     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Smith C.P., Chancellor M.B.: J. Urol. 171, 2128 (2004).
2. Cruz F., Dinis P.: Neurourol. Urodyn. 26 (Suppl. 6), 920 (2007).
3. Schurch B., Stohrer M., Kramer G., Schmid D.M., Gaul G., Hauri D.: J. Urol. 164, 692 (2000).
4. Doggweiler R., Zermann D.H., Ishigooka M., Schmidt R.A.: Prostate 37, 44 (1998).
5. Chuang Y.C., Chiang P.H., Huang C.C., Yoshimura N., Chancellor M.B.: Urology 66, 775 (2005).
6. Maria G., Brisinda G., Civello I.M., Bentivoglio A.R., Sganga G., Albanese A.: Urology 62, 259 (2003).
7. Kuo H.C.: Urology 65, 670 (2005).
8. Silva J., Silva C., Saraiva L., Silva A., Pinto R., Dinis P., Cruz F.: Eur. Urol. 53, 153 (2008).
9. Kuo H.C., Liu H.T.: Scand. J. Urol. Nephrol. 43, 206 (2009).
10. Guercini F., Giannantoni A., Bard R.L., Brisinda G., Cadeddu F., Maria G., Rossi P., Pajoncini C., Porena M.: J. Urol. 173 (Suppl.), 376 (2005).
11. Brisinda G., Cadeddu F., Vanella S., Mazzeo P., Marniga G., Maria G.: Urology 73, 90 (2009).
12. Kessler T.M., Khan S., Panicker J.N., Elneil S., Brandner S., Fowler C.J., Roosen A.: Eur. Urol. 57, 879 (2010).
13. Smith C.P., Franks M.E., McNeil B.K., Ghosh R., de Groat W.C., Chancellor M.B., Somogyi G.T.: J. Urol. 169, 1896 (2003).
14. Silva J., Pinto R., Carvallho T., Coelho A., Avelino A., Dinis P., Cruz F.: Eur. Urol. 56, 134 (2009).
15. Witte L.P.W., Chapple C.R., de la Rosette J.J.M.C.H., Michel M.C.: Eur. Urol. 54, 326 (2008).
16. Pennefather J.N., Lau W.A., Mitchelson F., Ventura S.: Auton. Pharmacol. 20, 193 (2000).
17. Park D.S., Cho T.W., Lee Y.K., Lee Y.T., Hong Y.K., Jang W.K.: Yons. Med. J. 47, 706 (2006).